Election 2014
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G) SET SMS ALERT

80.424
0.56 (0.70%)
NAV as on Apr-17-2014
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on Apr-17-2014)

Period Returns (%) Rank #
1 mth 0.6 6
3 mth 4.0 2
6 mth 11.2 4
1 year 29.4 3
2 year 27.6 1
3 year 22.3 1
5 year 32.8 2

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2014 4.2 - - - -
2013 -3.0 9.0 6.4 8.4 25.7
2012 9.4 5.5 12.4 6.3 37.3
2011 -6.1 6.8 -8.3 2.9 -5.6
2010 4.6 9.8 -0.3 9.5 29.6
2009 -11.3 43.8 26.2 -0.2 81.2

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 0.6 4.0 11.2 29.4 27.6 22.3 32.8
Category avg 1.4 3.4 13.4 28.9 11.7 9.1 15.5
Difference of Fund returns and Category returns -0.8 0.6 -2.2 0.5 15.9 13.2 17.3
Best of category 1.9 4.1 18.4 30.3 27.6 22.3 33.6
Worst of category 0.6 2.4 10.4 27.1 20.9 15.7 26.4
Benchmark returns # 2.8 3.3 8.9 24.5 25.1 20.0 28.3
Difference of Fund returns and Benchmark returns -2.2 0.7 2.3 4.9 2.5 2.3 4.5
# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jul 31, 1999
Benchmark S&P BSE HEALTHCARE
Asset Size (Rs cr) 130.15 (Dec-31-2013)
Minimum Investment Rs.50000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Tanmaya Desai
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 0.00%
Load Comments Exit load charge will be nil w.e.f. Oct 10, 2013.

Contact Details

Regd. Office 191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No. 91 22 22180221/ 27
Fax No. 91 22 22189663
Email partnerforlife@sbimf.com
Website http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
703.28 3.4 17.9 28.7 16.8 33.6
SBI Pharma Fund (G) Not Ranked
130.15 4.0 11.2 29.4 22.3 32.8
SBI Pharma Fund - Direct (G) Not Ranked
16.29 4.1 11.6 30.3 -- --
UTI Pharma & Health (G) Not Ranked
128.70 2.4 10.4 27.1 15.7 26.4
UTI Pharma & Health - Direct (G) Not Ranked
2.62 2.6 10.8 28.1 -- --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Feb 28, 14)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 56.56 24.97
Dr Reddys Labs Pharmaceuticals 39.17 17.30
Lupin Pharmaceuticals 25.83 11.40
Divis Labs Pharmaceuticals 15.65 6.91
Glenmark Pharmaceuticals 13.68 6.04
Cipla Pharmaceuticals 13.45 5.94
Ipca Labs Pharmaceuticals 11.98 5.29
Cadila Health Pharmaceuticals 11.41 5.04
Alembic Pharma Pharmaceuticals 7.36 3.25
Aurobindo Pharm Pharmaceuticals 6.55 2.89

Full Portfolio

Sector Allocation (Feb 28, 14)

Sector %

1-Year

HighLow

Pharmaceuticals 98.66 99.28 90.55

View All Sectors

Asset Allocation (%)(Feb 28, 14)

Equity 98.66
Others 0.00
Debt 0.00
Mutual Funds N.A
Money Market 3.09
Cash / Call -1.75

View All

Concentration

Holdings (%)
Top 5 66.62
Top 10 89.03
Sector (%)
Top 3 98.66

News & Videos

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.